September 19, 2013
The Ministry of Health, Labor and Welfare (MHLW)issued a notification on September 17, requiring revisions to the precautions sections of package inserts for 11 drugs including the angiotensin receptor blocker losartan potassium (original product: Nu-lotan) and Astellas Pharma’s anti-inflammatory agent...read more